Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds U.S. House Of Representatives Backs Record $858B Defense Authorization Bill, Voting Continues

U.S. House Of Representatives Backs Record $858B Defense Authorization Bill, Voting Continues

-Reuters

byMichael Horton

December 8, 2022

1 minute read

-Reuters

Funko, Inc. Announces Brian Mariotti To Take Leave Of Absence And Cease Serving As Co’s CEO, Michael Lunsford To Serve As Interim CEO

By Benzinga Newsdesk

July 13, 4:40 PM

Board Member Michael Lunsford Named Interim CEOFunko, Inc. ("Funko") (NASDAQ:FNKO), a leading pop culture lifestyle brand, announced that Brian Mariotti will take a leave of absence and cease serving as Funko's CEO with

FNKO

News
Tech

From Home Screen Customization To Call Recording And More: Did Apple Take Inspiration From These Long-Available Android Features For iOS 18?

By Rounak Jain

June 11, 9:14 AM

Many of the new features that Apple showed off in iOS 18 have already been available in Android devices for a long time now.

AAPL

News

U.S. Says Passenger Air Travel Service Complaints Jumped 35% In June Over May And Are Up 270% Over Pre-Pandemic Levels

By Benzinga Newsdesk

August 26, 11:08 AM

-Reuters

AAL

AstraZeneca Joins Anti-Obesity Race Dominated By Eli Lilly And Novo Nordisk, Reports Mixed Q3 Earnings

By Vandana Singh

November 9, 10:10 AM

AstraZeneca Plc (NASDAQ: AZN) has reported Q3 FY23 core EPS of $1.73, u

AZN

U.S. House Of Representatives Backs Record $858B Defense Authorization Bill, Voting Continues

Related Posts

Funko, Inc. Announces Brian Mariotti To Take Leave Of Absence And Cease Serving As Co’s CEO, Michael Lunsford To Serve As Interim CEO

From Home Screen Customization To Call Recording And More: Did Apple Take Inspiration From These Long-Available Android Features For iOS 18?

U.S. Says Passenger Air Travel Service Complaints Jumped 35% In June Over May And Are Up 270% Over Pre-Pandemic Levels

AstraZeneca Joins Anti-Obesity Race Dominated By Eli Lilly And Novo Nordisk, Reports Mixed Q3 Earnings